ATE210680T1 - Antikörper gegen hypophysäre adenylatzyklase aktivierende peptid-pacap, hybridome und bestimmung von pacap - Google Patents

Antikörper gegen hypophysäre adenylatzyklase aktivierende peptid-pacap, hybridome und bestimmung von pacap

Info

Publication number
ATE210680T1
ATE210680T1 AT91906251T AT91906251T ATE210680T1 AT E210680 T1 ATE210680 T1 AT E210680T1 AT 91906251 T AT91906251 T AT 91906251T AT 91906251 T AT91906251 T AT 91906251T AT E210680 T1 ATE210680 T1 AT E210680T1
Authority
AT
Austria
Prior art keywords
pacap
pct
hypophysic
hybridomas
antibodies
Prior art date
Application number
AT91906251T
Other languages
English (en)
Inventor
Nobuhiro Suzuki
Chieko Kitada
Masao Tsuda
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of ATE210680T1 publication Critical patent/ATE210680T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57563—Vasoactive intestinal peptide [VIP]; Related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT91906251T 1990-03-17 1991-03-15 Antikörper gegen hypophysäre adenylatzyklase aktivierende peptid-pacap, hybridome und bestimmung von pacap ATE210680T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP6556590 1990-03-17
JP28711590 1990-10-26
PCT/JP1991/000354 WO1991014786A1 (en) 1990-03-17 1991-03-15 Antibody to pituitary adenylate cyclase activating peptide-pacap, hybridoma and assay for pacap

Publications (1)

Publication Number Publication Date
ATE210680T1 true ATE210680T1 (de) 2001-12-15

Family

ID=26406709

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91906251T ATE210680T1 (de) 1990-03-17 1991-03-15 Antikörper gegen hypophysäre adenylatzyklase aktivierende peptid-pacap, hybridome und bestimmung von pacap

Country Status (7)

Country Link
US (1) US5486472A (de)
EP (1) EP0522159B1 (de)
JP (1) JP3107225B2 (de)
AT (1) ATE210680T1 (de)
CA (1) CA2077764C (de)
DE (1) DE69132864T2 (de)
WO (1) WO1991014786A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3110349B2 (ja) 1997-07-02 2000-11-20 日本電気株式会社 フレームアライナ回路
WO1999051762A1 (en) * 1998-04-03 1999-10-14 Millennium Pharmaceuticals, Inc. Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
US6972319B1 (en) 1999-09-28 2005-12-06 Bayer Pharmaceuticals Corporation Pituitary adenylate cyclase activating peptide (PACAP)receptor 3 (R3) agonists and their pharmacological methods of use
RU2269354C2 (ru) * 1999-09-28 2006-02-10 Байер Корпорейшн Агонисты рецептора-3(r3) пептида-активатора гипофизарной аденилатциклазы(расар) и способы их фармакологического применения
US7507714B2 (en) 2000-09-27 2009-03-24 Bayer Corporation Pituitary adenylate cyclase activating peptide (PACAP) receptor 3 (R3) agonists and their pharmacological methods of use
JP2003161732A (ja) * 2001-11-28 2003-06-06 Itoham Foods Inc 神経ペプチドの定量方法
WO2004062684A2 (en) * 2003-01-16 2004-07-29 D. Collen Research Foundation Vzw Onderwijs En Navorsing Campus Gasthuisberg K.U. Leuven Treatment of thrombocytopenia with inhibitors of pacap
WO2012106407A2 (en) * 2011-02-01 2012-08-09 The University Of Vermont And State Agricultural College Diagnostic and therapeutic methods and products related to anxiety disorders
TWI636064B (zh) 2013-03-15 2018-09-21 安美基公司 人類ｐａｃ１抗體
CA2960756C (en) 2014-09-15 2023-08-01 Amgen Inc. Bi-specific anti-cgrp receptor/pac1 receptor antigen binding proteins and uses thereof
JP6752223B2 (ja) 2015-04-16 2020-09-09 アルダー・バイオファーマシューティカルズ・インコーポレーテッド 羞明を処置、予防、または阻害するための抗ｐａｃａｐ抗体及びそれらの抗原結合性断片の使用
EP3390447A1 (de) 2015-12-15 2018-10-24 Amgen Inc. Pacap-antikörper und verwendungen davon
CA3020839A1 (en) * 2016-04-15 2017-10-19 Alder Biopharmaceuticals, Inc. Anti-pacap antibodies and uses thereof
AR113022A1 (es) * 2017-09-29 2020-01-15 Lilly Co Eli Anticuerpo anti-pacap
US10738110B2 (en) 2018-01-12 2020-08-11 Amgen Inc. PAC1 antibodies and uses thereof
CA3168991A1 (en) * 2020-01-23 2021-07-29 United Biomedical, Inc. Peptide immunogens targeting pituitary adenylate cyclase-activating peptide (pacap) and formulations thereof for prevention and treatment of migraine
CN111892175B (zh) * 2020-07-31 2022-07-19 江苏省农业科学院 一种多孔炭强化微生物挂膜载体材料的制备方法及应用
JP2024527029A (ja) 2021-07-29 2024-07-19 セファロン リミティド ライアビリティ カンパニー 抗ｐａｃａｐ抗体の組成物及び方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5198542A (en) * 1989-06-20 1993-03-30 Takeda Chemical Industries, Inc. Dna encoding a pitvitary adenylate cyclase activating protein and use thereof

Also Published As

Publication number Publication date
EP0522159B1 (de) 2001-12-12
EP0522159A1 (de) 1993-01-13
DE69132864T2 (de) 2002-08-08
JP3107225B2 (ja) 2000-11-06
DE69132864D1 (de) 2002-01-24
WO1991014786A1 (en) 1991-10-03
US5486472A (en) 1996-01-23
JPH06500001A (ja) 1994-01-06
CA2077764A1 (en) 1991-09-18
CA2077764C (en) 2002-12-10

Similar Documents

Publication Publication Date Title
ATE210680T1 (de) Antikörper gegen hypophysäre adenylatzyklase aktivierende peptid-pacap, hybridome und bestimmung von pacap
Wenzel et al. Immunoassay of tryptase from human mast cells
ATE216779T1 (de) Immunoassays für anti-hcv-antikörper unter verwendung von antigenen mit konformationsepitopen
DK261386A (da) Monoklonale antistoffer
ATE175241T1 (de) Antikörper gegen alpha v beta 3 integrin
DE69833118D1 (de) Immunoassay zum bestimmen von bnp
IL149062A0 (en) Improved method for detecting acid resistant microorganisms in the stool
ATE333649T1 (de) Immunotestverfahren für herz-troponin i
ATE331952T1 (de) Bestimmung von spezifischem immunglobulin unter verwendung multipler antigene
KR910021585A (ko) 알쯔하이머병의 진단 분석법
KR890015714A (ko) 폐암의 조기 검출 방법
DK0460190T3 (da) Fremgangsmåde til påvisning af maligne sygdomme
ATE320604T1 (de) Homogene nachweisverfahren zur bestimmung von subpopulationen eines analyten
DK0455707T3 (da) Blodkoagulationsfaktor betaXIIa monoklonalt antistof og immunassay
KR960014336A (ko) 사람 글리센틴에 대한 모노클로날 항체, 이러한 항체를 생성하기 위한 하이브리도마 및 상기 항체를 사용한 사람 글리센틴의 검정방법
NO179107C (no) Monoklonalt antistoff for selektiv immunologisk bestemmelse av intakt prokollagen-peptid (type III) og prokollagen (type III) i kroppsvæsker, hybridom-cellelinje, anvendelse av antistoffene og diagnostiske sett
EP0194158A3 (de) Anti-Nikotin- und Anti-Kotinin-Antikörper (monoklonale und andere) und deren Verwendungen in Nikotin- und Kotinin-Testverfahren
DE3674933D1 (de) Spezifisch hemmender speichel-alpha-amylase monoklonaler antikoerper und dessen verwendung zur bestimmung von pankreas-alpha-amylase.
IL97350A0 (en) Hybridomas producing monoclonal antibodies specific for metolachlor,such antibodies and their use in immunoassays for metolachlor
Daniels et al. FURTHER ANALYSIS OF THE MONOCLONAL ANTIOBODY H8 DEMONSTRATING A JMH‐RELATED SPECIFICITY
KR940018099A (ko) 메발론산에 대한 항체 및 메발론산의 정량 방법
Ferreira et al. Use of the ELISA to detect and quantify histocompatibility antigens and their subunits
CA2095735A1 (en) Monoclonal antibodies to hepatitis c virus and method for using same
NO852058L (no) Fremgangsmaate og middel for bestemmelse av atl virus antistoffer.
ES552074A0 (es) Un metodo en emparedado de doble anticuerpo para detectar o ensayar un antigeno seleccionado de urocinasa humana y un precursor de la misma